- Barrons.com
New Weight-Loss Drugs and Devices Are Coming This Week
Weight-loss breakthroughs all emerged from diabetes treatment. Meetings such as the coming American Diabetes Association are increasingly dominated by news on obesity drugs.
- Investor's Business Daily
Top Weight-Loss Rivals Share This Risk After Eye-Popping Runs
Popular weight-loss drugs have boosted Novo Nordisk and Eli Lilly. After huge gains, the drugmakers' stocks now face this risk.
- Barrons.com
Broadcom Is on Track to Edge Past Eli Lilly’s Market Value. AI Is Helping It Do So.
Over its current seven-day streak in the green, Broadcom has snapped up market value that is around the equivalent to McDonald’s.
